T0	Disease 74 76	EC
#1	AnnotatorNotes T0	DOID:1380
T12	Disease 760 767	tumours
#4	AnnotatorNotes T12	DOID:162
T13	Disease 831 868	chemotherapy-resistant ovarian cancer
#5	AnnotatorNotes T13	DOID:2394
T14	Chemical 950 958	estrogen
T16	Disease 1000 1006	tumors
T18	Disease 1040 1053	breast cancer
#8	AnnotatorNotes T18	DOID:1612
T19	Disease 1197 1214	pancreatic cancer
#9	AnnotatorNotes T19	DOID:1793
T2	Disease 242 244	EC
T24	Drug 1372 1375	FTS
T25	Drug 1391 1400	Salirasib
T26	Disease 1412 1417	tumor
#17	AnnotatorNotes T26	DOID:162
T27	Disease 1558 1564	tumors
T5	Disease 471 486	cervical cancer
#19	AnnotatorNotes T5	DOID:4362
T6	Drug 542 564	5-aza-2â€²-deoxycytidine
T8	Drug 580 590	Decitabine
T9	Disease 645 660	cervical cancer
T1	Gene-Protein 261 265	UTF1
#2	AnnotatorNotes T1	HGNC:12634
T3	Biomarker 261 310	UTF1 had the greatest differential RNA expression
T4	Gene-Protein 379 383	UTF1
T10	Biomarker 355 383	Increased expression of UTF1
T15	Biomarker 400 432	hypermethylation of its promoter
T17	Collection 355 432	Increased expression of UTF1 (resulting from hypermethylation of its promoter
R1	Association Arg1:T17 Arg2:T5	
T28	GeneFamily 517 538	DNA methyltransferase
#6	AnnotatorNotes T28	family:1884
#10	AnnotatorNotes T6	CHEMBL1201129
#11	AnnotatorNotes T8	CHEMBL1201129
T7	Gene-Protein 601 605	UTF1
T29	Gene-Protein 693 700	SLC14A2
#12	AnnotatorNotes T29	HGNC:10919
T11	Biomarker 693 732	SLC14A2, which was significantly higher
R3	Association Arg1:T11 Arg2:T12	
T30	Drug-Class 831 843	chemotherapy
T31	Biomarker 950 991	estrogen-target gene TFF1 was upregulated
R4	Association Arg1:T31 Arg2:T16	
T32	Gene-Protein 971 975	TFF1
#3	AnnotatorNotes T32	HGNC:11755
T33	Gene-Protein 1008 1012	TFF1
T34	Biomarker 1008 1012	TFF1
#7	AnnotatorNotes T34	C051838
R5	Association Arg1:T34 Arg2:T36	
R6	Prognostic-Poor Arg1:T34 Arg2:T19	
T35	Disease 1077 1092	bone metastasis
#13	AnnotatorNotes T35	DOID:184
T36	Collection 1040 1092	breast cancer development [ 29 ] and bone metastasis
T37	Drug 1276 1313	progestin medroxyprogesterone acetate
#14	AnnotatorNotes T37	CHEMBL717
#15	AnnotatorNotes T24	CHEMBL23293
#16	AnnotatorNotes T25	CHEMBL23293
R7	Synergy-Response Arg1:T37 Arg2:T23	
T21	Gene-Protein 1512 1516	TFF1
T22	GeneFamily 1485 1487	ER
#20	AnnotatorNotes T22	not found
T23	Collection 1412 1447	tumor growth and enhanced type 2 EC
T38	Disease 1438 1447	type 2 EC
#18	AnnotatorNotes T38	not found
T20	Disease 1569 1579	type 2 ECs
#21	AnnotatorNotes T20	not found
T39	Drug 1342 1370	S-farnesylthiosalicylic acid
#22	AnnotatorNotes T39	CHEMBL23293
T40	Drug-Class 1328 1341	Ras inhibitor
R2	Synergy-Response Arg1:T39 Arg2:T23	
T41	Drug 1315 1318	MPA
#23	AnnotatorNotes T41	CHEMBL717
